trending Market Intelligence /marketintelligence/en/news-insights/trending/ud7znkdm77ionxu5y5ia6q2 content esgSubNav
In This List

LexaGene Holdings names director

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


LexaGene Holdings names director

LexaGene Holdings Inc. appointed Joseph Caruso as a board member.

Caruso currently serves as a board member of Endocellutions Inc., a privately held medical device company. He was a member of Launchpad Venture Group, a Boston-based investment group providing funding and advice to early stage companies, from 2016 to 2018.

Lexagene Holdings engages in the research, development and commercialization of pathogen detection devices to the bio-chemical industry in the U.S.